Project Details
| Status | Active |
|---|---|
| Effective start/end date | 5/6/24 → 5/6/27 |
Funding
- PPD Investigator Services, LLC (Prot #REC-4881-221 // Prot #REC-4881-221)
- Recursion Pharmaceuticals, Inc. (Prot #REC-4881-221 // Prot #REC-4881-221)
Prot #REC-4881-221: A Phase 2, Open Label Study of REC-4881 in Participants with Unresectable Locally Advanced or Metastatic Cancer with AXIN1 or APC Mutation
- Kalyan, Aparna (PD/PI)
Project: Research project